Concepedia

Author

Christopher Carter

Laboratoire de Synthèse OrganiqueORCID

Also Known As

C CARTER, C Carter, C J Carter, C. CARTER, C. Carter, C. J. CARTER, C. J. Carter, C.J. Carter, C.J. Chris Carter, CEDRIC J. CARTER

205

Publications

18K

Citations

54

H-Index

183

Concepts

All Affiliations

Laboratoire de Synthèse OrganiqueUniversity of BristolEast Sussex County CouncilBrock UniversityKing's College London
CC

About

Christopher Carter is an author at Laboratoire de Synthèse Organique specializing in medicine, neuroscience, and social sciences.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

33

61

9.3K

2

Social Sciences

21

28

2.2K

3

Natural Sciences

5

5

178

4

Health Sciences

4

4

105

5

Public Health

2

2

52

Christopher Carter

×

85

Publications

11.9K

Citations

42

H-Index

YearCitations

BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis

Scott M. Wilhelm, Christopher Carter, LiYa Tang,

Cancer Research

2004

4K

Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease

David T. Dexter, Christopher Carter, F. R. Wells,

Journal of Neurochemistry

1989

1.4K

Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats

C Pycock, Robert Kerwin, Christopher Carter

Nature

1980

550

Fractalkine modulates TNF-? secretion and neurotoxicity induced by microglial activation

Violetta Zujovic, Jes�s Benavides, Xavier Vig�,

Glia

2000

378

Sequence Identification and Characterization of Human Carnosinase and a Closely Related Non-specific Dipeptidase

Michael Teufel, Vladimı́r Saudek, Jean-Pierre Ledig,

Journal of Biological Chemistry

2003

340

Effect of 6‐Hydroxydopamine Lesions of the Medial Prefrontal Cortex on Neurotransmitter Systems in Subcortical Sites in the Rat

C Pycock, Christopher Carter, Robert Kerwin

Journal of Neurochemistry

1980

247

Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. I. Evidence for efficacy in models of focal cerebral ischemia.

Bernard Gotti, D. Duverger, John Bertin,

Journal of Pharmacology and Experimental Therapeutics

1988

246

Behavioural and biochemical effects of dopamine and noradrenaline depletion within the medial prefrontal cortex of the rat

Christopher Carter, C Pycock

Brain Research

1980

224

Aspirin and Salicylate Protect Against MPTP‐Induced Dopamine Depletion in Mice

Nadine Aubin, O. Curet, Annie Deffois,

Journal of Neurochemistry

1998

215

Presynaptic alpha-2 adrenoceptors play a major role in the effects of idazoxan on cortical noradrenaline release (as measured by in vivo dialysis) in the rat.

T Dennis, Rémy L'Heureux, Christopher Carter,

Journal of Pharmacology and Experimental Therapeutics

1987

200

Page 1